Related Experiment Video
Updated: Sep 24, 2025

Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR
Published on: December 6, 2014
SCID and Other Inborn Errors of Immunity with Low TRECs - the Brazilian Experience
Lucila Akune Barreiros1, Jusley Lira Sousa1, Christoph Geier2
1Laboratory of Human Immunology, Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, 1730, Av. Professor Lineu Prestes, Sao Paulo, SP, 05508-000, Brazil.
Insights
Severe combined immunodeficiency (SCID) is a critical pediatric emergency. Early diagnosis and treatment are vital, as delays significantly reduce survival rates and treatment success in Brazilian patients.
Area of Science:
- Immunology
- Pediatrics
- Genetics
Background:
- Severe combined immunodeficiency (SCID) is a life-threatening pediatric emergency caused by absent or non-functional T cells.
- Infants with SCID often appear healthy at birth, necessitating newborn screening (NBS) for early detection before severe infections occur.
- Delayed diagnosis and treatment in Brazil lead to poor outcomes, highlighting the need for improved screening and medical education.
Purpose of the Study:
- To report on 47 Brazilian patients investigated for SCID between 2009 and 2020.
- To analyze diagnostic delays, treatment outcomes, and survival rates in SCID patients in Brazil.
- To assess the impact of improved medical education and advocate for universal NBS-SCID implementation.
Main Methods:
- Retrospective analysis of 47 Brazilian patients with suspected SCID based on clinical presentation, family history, or low TRECs.
- Clinical and laboratory findings, genetic testing, and treatment outcomes were reviewed.
- Survival rates and the success of hematopoietic stem-cell transplantation were evaluated.
Main Results:
- 24 typical SCID, 14 leaky SCID, and 6 Omenn syndrome cases were diagnosed among the 47 patients.
- Median age at onset was 2 months, but diagnosis and treatment were delayed to 6.5 and 11.5 months, respectively.
- Overall survival was 51.1%, with only 66.7% undergoing transplantation, which was successful in 70% of those cases. Genetic testing success rate was 65.1%.
Conclusions:
- Significant diagnostic and treatment delays impact SCID patient survival in Brazil.
- Improved medical education has aided SCID diagnosis, but an estimated 80% of cases remain missed.
- Universal NBS-SCID implementation, starting in São Paulo, is crucial for early diagnosis and improved survival rates for SCID patients in Brazil.
Abstract:
Severe combined immunodeficiency, SCID, is a pediatric emergency that represents the most critical group of inborn errors of immunity (IEI). Affected infants present with early onset life-threatening infections due to absent or non-functional T cells. Without early diagnosis and curative treatment, most die in early infancy. As most affected infants appear healthy at birth, newborn screening (NBS) is essential to identify and treat patients before the onset of symptoms. Here, we report 47 Brazilian patients investigated between 2009 and 2020 for SCID due to either a positive family history and/or clinical impression and low TRECs. Based on clinical presentation, laboratory finding, and genetic information, 24 patients were diagnosed as typical SCID, 14 as leaky SCID, and 6 as Omenn syndrome; 2 patients had non-SCID IEI, and 1 remained undefined. Disease onset median age was 2 months, but at the time of diagnosis and treatment, median ages were 6.5 and 11.5 months, respectively, revealing considerable delay which affected negatively treatment success. While overall survival was 51.1%, only 66.7% (30/45) lived long enough to undergo hematopoietic stem-cell transplantation, which was successful in 70% of cases. Forty-three of 47 (91.5%) patients underwent genetic testing, with a 65.1% success rate. Even though our patients did not come from the NBS programs, the diagnosis of SCID improved in Brazil during the pilot programs, likely due to improved medical education. However, we estimate that at least 80% of SCID cases are still missed. NBS-SCID started to be universally implemented in the city of São Paulo in May 2021, and it is our hope that other cities will follow, leading to early diagnosis and higher survival of SCID patients in Brazil.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
13:55Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cell-mediated Immune Responses
Inborn Errors of Metabolism